|
DRUG USE CONSEQUENCES
Table 23. Estimated Number of Deaths of Persons with AIDS1 by Sex and Exposure Category, 1993�1999
|
Sex
|
Exposure Category
|
|
|
Men who have sex with men (MSM)
|
Injecting drug use (IDU)
|
MSM and IDU
|
Hemo-
philia/co-
agulation disorder
|
Hetero-
sexual contact
|
Receipt of blood trans-
fusion2
|
Risk not reported or identified
|
Total
|
Percent drug-
related3
|
|
Male adult/adolescent
|
|
1993
|
23,904
|
9,298
|
3,184
|
356
|
1,591
|
314
|
170
|
38,818
|
32.1%
|
|
1994
|
25,398
|
10,387
|
3,503
|
348
|
2,010
|
307
|
147
|
42,100
|
33.0%
|
|
1995
|
24,914
|
10,786
|
3,436
|
331
|
2,388
|
262
|
102
|
42,220
|
33.6%
|
|
1996
|
16,847
|
8,527
|
2,585
|
248
|
2,108
|
216
|
68
|
30,601
|
36.3%
|
|
1997
|
8,695
|
5,369
|
1,445
|
137
|
1,473
|
107
|
45
|
17,271
|
39.4%
|
|
1998
|
6,983
|
4,416
|
1,242
|
115
|
1,214
|
83
|
29
|
14,081
|
40.1%
|
|
1999
|
6,069
|
4,041
|
1,124
|
98
|
1,230
|
70
|
27
|
12,660
|
40.7%
|
|
Female adult/adolescent
|
|
1993
|
N/A
|
3,124
|
N/A
|
17
|
2,656
|
239
|
76
|
6,132
|
51.2%
|
|
1994
|
N/A
|
3,600
|
N/A
|
27
|
3,478
|
225
|
56
|
7,486
|
48.1%
|
|
1995
|
N/A
|
3,812
|
N/A
|
30
|
3,988
|
234
|
56
|
8,119
|
46.9%
|
|
1996
|
N/A
|
3,279
|
N/A
|
30
|
3,434
|
174
|
33
|
6,950
|
47.1%
|
|
1997
|
N/A
|
2,146
|
N/A
|
21
|
2,301
|
94
|
20
|
4,582
|
46.8%
|
|
1998
|
N/A
|
1,891
|
N/A
|
15
|
2,008
|
74
|
15
|
4,004
|
47.2%
|
|
1999
|
N/A
|
1,891
|
N/A
|
16
|
1,989
|
73
|
19
|
3,989
|
47.4%
|
N/A Not applicable.
1Excludes pediatric (<13 years old) AIDS cases. These numbers do not represent actual deaths of persons with AIDS.
Rather, they are point estimates adjusted for delays in the reporting of deaths and for redistribution of cases initially
reported with no identified risk, but not for incomplete reporting. Annual estimates are through the most recent year
for which reliable estimates are available.
2Includes receipt of blood components or tissue.
3Proportion includes injection drug users and MSM who are injection drug users.
Source: Centers for Disease Control and Prevention, HIV/AIDS Surveillance Report, 2000, 12 (2) 2001, Table 30.
|
